A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy
Clinical trial NCT04732286 · TERMINATED
Trial details
- NCT number
- NCT04732286
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2024-04-26
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.